As of April 19, 2025, Alto Neuroscience (ANRO) has a market cap of $61.183 million USD. According to our data, Alto Neuroscience is ranked No.7930 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $61.18 M |
-46.37%
|
Dec 31, 2024 | $0.11 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Sage Therapeutics
SAGE
|
$0.46 B |
-0.000 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() Axsome Therapeutics
AXSM
|
$5.09 B |
-0.000 M
|
![]() USA
|
![]() Intra-Cellular Therapies
ITCI
|
$14.05 B |
0.000 M
|
![]() USA
|
![]() ACADIA Pharmaceuticals
ACAD
|
$2.46 B |
0.000 M
|
![]() USA
|
![]() Vanda Pharmaceuticals
VNDA
|
$0.25 B |
-0.000 M
|
![]() USA
|
![]() Neurocrine Biosciences
NBIX
|
$10.03 B |
-0.000 M
|
![]() USA
|
![]() Alkermes
ALKS
|
$4.45 B |
-0.000 M
|
![]() Ireland
|
![]() Jazz Pharmaceuticals
JAZZ
|
$6.24 B |
0.000 M
|
![]() Ireland
|
![]() Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
![]() USA
|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$306.02 B |
0.008 M
|
![]() USA
|
Market Cap | = | ANRO Stock Price | * | ANRO Shares Outstanding |
= | $2.26 | * | 27.07 M | |
= | $61.18 M |